Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data

• Clinical Intervention

• We will be conducting a quasi-experimental study of a new sub-acute stabilization center (SASC) for those at high risk or who have had an opioid overdose to which Seattle Fire/EMS refer. All eligible people at risk or post OD who encounter Seattle Fire/EMS will potentially be offered the intervention, and those interested and transported will be considered study participants, there is no study assignment (anticipated n=5,495).
• Comparison groups will be identified from secondary EMS records data for Seattle (anticipated n=7,223) and the remainder of King County, WA (anticipated n=11,550).
• People 18 and older who EMS encounter who have had or are at high risk for any opioid overdose and meet clinical inclusion criteria.
• SASC services will be provided by Downtown Emergency Service Center's Overdose Recovery and Care Access Centers:

• 515 Third Avenue, Seattle, WA 98104
• 517 Third Avenue, Seattle, WA 98104
• 1600 South Lane Street Seattle, WA 98144
• Implementation research interviews with professional stakeholders

• We will be conducting repeated cross-sectional interviews with professional stakeholders about the implementation of the SASC and CPI activities.
• Participants will be 18 or older and include people such as: CPI meeting attendees, EMS personnel, and SASC staff (n=60).
• It is anticipated that stakeholder interviews will be conducted virtually via video conferencing with study team members.
• Implementation research surveys with people with lived experience of drug use

• We will be utilizing a combination of data sources. Initially in-person interview data from the 1R01DA059011-01 study (Van Draanen, PI) will be utilized for analyses.
• Participants from the Van Draanen study will be 18 or older who have have survived a non-fatal opioid overdose and had an emergency medical service interaction or intervention (n=80).
• If needed, we will also, subsequently conduct repeated cross-sectional surveys with people with lived experience of drug use about their experiences and perceptions of the SASC. Final procedures will be determined in collaboration with our community partner the Lived Expertise Advisory Board.

Inclusion criteria

• Verbally consents to transfer of care to SASC.
• Awake and oriented to person and place, with no significant deficits in mental status or neurological function.
• Age >=18
• Patent airway and effective respirations with adequate oxygenation.
• Stable heart rate and blood pressure, with no evidence of cardiac arrhythmias or other significant cardiovascular disfunction.
• Vitals:

• Heart rate: 45-130
• Blood pressure: systolic 95-190, diastolic 50-120
• Respiratory rate: 10-24
• SpO2: >92 on room air or supplemental O2 via nasal cannula.
• SpO2 <92% with supplemental O2 requires ED transfer.
• EtCO2: <50
• Temperature: 95.5-100.3 F
• Blood glucose (if indicated): 60-300
• No signs of head trauma:

• Dizziness or loss of balance
• Blurred vision or double vision
• Sensitivity to light or noise
• Seizures or convulsions
• Weakness or numbness in the arms or legs
• Persistent or worsening headache
• CSF or blood leaking from the nose or ears
• Unequal pupils or pupils that are slow to react to light.
• No signs of other traumatic injury or medical needs requiring immediate treatment.
• No signs of respiratory infection. Screen for COVID-19. See COVID-19 Screening protocol.

Exclusion criteria

• People under 18 and who do not meet SASC admission criteria will be excluded.